Huntington National Bank’s Editas Medicine EDIT Stock Holding History

Huntington National Bank’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-32	Closed	-$250	–	3891
2023 Q3	$250	Hold	32	–	–	﹤0.01%	2312
2023 Q2	$263	Buy	+32	New	+$279	﹤0.01%	2274
2022 Q4	–	Sell	-405	Closed	-$5K	–	3533
2022 Q3	$5K	Hold	405	–	–	﹤0.01%	1699
2022 Q2	$4K	Hold	405	–	–	﹤0.01%	1768
2022 Q1	$7K	Hold	405	–	–	﹤0.01%	1678
2021 Q4	$10K	Sell	405 -140	-26%	-$4.82K	﹤0.01%	1572
2021 Q3	$22K	Buy	545 +140	+35%	+$7.67K	﹤0.01%	1218
2021 Q2	$23K	Hold	405	–	–	﹤0.01%	1183
2021 Q1	$17K	Hold	405	–	–	﹤0.01%	1184
2020 Q4	$28K	Buy	405 +30	+8%	+$1.23K	﹤0.01%	992
2020 Q3	$11K	Hold	375	–	–	﹤0.01%	1198
2020 Q2	$11K	Hold	375	–	–	﹤0.01%	1181
2020 Q1	$7K	Buy	+375	New	+$9.46K	﹤0.01%	1266

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Huntington National Bank's EDIT Position: Q4 2023 in Review

Huntington National Bank sold out of Editas Medicine (EDIT) in Q4 2023, closing a stake of 32 shares — an estimated $250 sold.

Huntington National Bank first reported a position in EDIT in Q1 2020 and held it in 13 quarters. The position peaked at $28K in Q4 2020. 225 funds tracked by Wall St. Rank hold EDIT as of Q4 2023.

Huntington National Bank reported no remaining Editas Medicine position as of Q4 2023 after selling out during the quarter.
Huntington National Bank sold 32 Editas Medicine shares in Q4 2023, an estimated $250.
Huntington National Bank first reported a position in Editas Medicine in Q1 2020 and held it in 13 quarters.
Huntington National Bank's Editas Medicine position peaked at $28K in Q4 2020.
225 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2023.

Based on Huntington National Bank's 13F filing for Q4 2023, filed 7 Feb 2024.